Work

Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6–8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2024.03.056

Authors: Ramesh V. Matur, Subhash Thuluva, Subbareddy Gunneri, Vijay Yerroju, Rammohan reddy Mogulla, Kamal Thammireddy, Piyush Paliwal, Niranjana S. Mahantshetty, Mandyam Dhati Ravi, S. Prashanth, Savita Verma, Jai Prakash Narayan

Institutions: Biological E (India), KLE Society Hospital, JSS Medical College and Hospital, Mysore Medical College, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences

Language: English

Topic: Pneumonia and Respiratory Infections

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4394880191

FWCI: 3.092

Cites: 31

Cited by: 11

Related to: 10